Universe Pharmaceuticals (UPC) Enterprise Value (2020 - 2025)
Universe Pharmaceuticals' Enterprise Value history spans 6 years, with the latest figure at -$33.6 billion for Q3 2025.
- For Q3 2025, Enterprise Value fell 108698.09% year-over-year to -$33.6 billion; the TTM value through Sep 2025 reached -$33.6 billion, down 108698.09%, while the annual FY2025 figure was -$33.6 billion, 108698.09% down from the prior year.
- Enterprise Value for Q3 2025 was -$33.6 billion at Universe Pharmaceuticals, down from -$30.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$21.8 million in Q3 2021 and bottomed at -$33.6 billion in Q3 2025.
- The 5-year median for Enterprise Value is -$5.3 billion (2023), against an average of -$8.9 billion.
- The largest annual shift saw Enterprise Value soared 99.42% in 2024 before it tumbled 108698.09% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$21.8 million in 2021, then plummeted by 26155.92% to -$5.7 billion in 2022, then rose by 7.65% to -$5.3 billion in 2023, then skyrocketed by 99.42% to -$30.9 million in 2024, then crashed by 108698.09% to -$33.6 billion in 2025.
- Per Business Quant, the three most recent readings for UPC's Enterprise Value are -$33.6 billion (Q3 2025), -$30.9 million (Q3 2024), and -$5.3 billion (Q3 2023).